jeudi 19 janvier 2017

Onco Actu du 19 janvier 2017

1. Biologie

Project to replicate landmark cancer studies meets mixed results [STAT]

What Does It Mean When Cancer Findings Can't Be Reproduced? [NPR]

Rigorous replication effort succeeds for just two of five cancer papers [Science]

At last, cancer reproducibility project releases some results — and they’re mixed [Retraction Watch]

Cancer reproducibility project releases first results [Nature]

Beyond base pairs: Two Broad cancer researchers on the study of structural variation in cancers [Broad Institute]

3.1 Tabac

The Global Economic Burden of Tobacco: An Interview with Dr. Mark Parascandola [NCI]

3.1.1 Tabac - e-cigs

Vape companies try to galvanize Trump administration to ease FDA rules [Reuters]

3.6 Prévention - Activité physique

Moderate exercise can improve outcomes for patients with metastatic colorectal cancer, study shows [Dana-Farber Cancer Institute]

4.2 Dép., diag. & prono. - Génome

DNA-testing smartphone aims to tackle drugs resistance [BBC News]

4.5 Dép., diag. & prono. - Colorectal

Live from inside the human body: robots, blue dye and bowel cancer [Cancer Research UK]

5.2 Pharma

Novartis chief Jimenez touts two top PhIII drug prospects [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications [FDA]

What Trump's Libertarian Pals Don't Understand About The FDA -- Or Reality [Forbes]

How the FDA Will Help Lead the Next Medical Revolution [Wired]

Netherlands bids to hosts EU drugs agency, replacing Britain [Reuters]

5.4 Traitements - Economie

Biosimilars Create Opportunities for Sustainable Cancer Care [ESMO]

Europe's oncologists back biosimilar versions of cancer drugs [Reuters]

5.5.5 ASCO (gastro-intestinal)

Bayer to Reveal Latest Data on Regorafenib at ASCO GI 2017 [Bayer]

2017 Symposium to Highlight Notable Research Advances in Gastrointestinal Cancers [ASCO]

6.12 Ethique

Scientists Needn't Get A Patient's Consent To Study Blood Or DNA [NPR]

David Shaw: The implications of conflicts of interest for informed consent [BMJ Blogs]

New rules ease consent requirements for scientists using patient specimens [STAT]

6.6 Publications

How to spot a “citation cartel” [Retraction Watch]

6.7 DMP, Big Data & applis

ASCO Chief Medical Officer Pens New Blog on Importance of Interoperability [ASCO]

Precision Medicine Gives People With Cancer New Hope In 2017 [Forbes]

Building The Value-Based Health Care System Of The Future Depends On Meeting Clinicians’ Data Needs [Health Affairs Blog]

6.9 Controverses

Why are we still talking about ‘ovarian’ cancer? [STAT]